about
The Metabolic Syndrome as a Risk Factor for Venous and Arterial ThrombosisStatins for acute ischemic strokeArterial indications for the low molecular weight heparinsD-dimer testing in the diagnosis of cerebral vein thrombosis: a systematic review and a meta-analysis of the literatureWhich patients with venous thromboembolism should receive non-vitamin K antagonist oral anticoagulants? The majorityNatural history of cerebral vein thrombosis: a systematic reviewUnsuspected pulmonary embolism in cancer patients: a narrative review with pooled data.Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? Yes.Seasonal variation in the occurrence of venous thromboembolism: data from the MASTER Registry.Inherited thrombophilic abnormalities and risk of portal vein thrombosis. a meta-analysis.The new oral anticoagulants, do they change the benefit vs. risk for thromboprophylaxis in association to ambulatory surgery?Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry.Low molecular weight heparin for the treatment of retinal vein occlusion: a systematic review and meta-analysis of randomized trials.Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience.XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis.New direct thrombin inhibitors.Practical management of coagulopathy associated with warfarin.Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Aspirin for preventing the recurrence of venous thromboembolism.Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature.Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysisThe role of thrombolytic therapy in pulmonary embolismUpdate on the diagnosis and management of pulmonary embolism.Retrievable vena cava filters: a review.Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms.Epidemiology and risk factors of venous thromboembolism.A case report and literature review of portal vein thrombosis associated with cytomegalovirus infection in immunocompetent patients.Prophylaxis and treatment of venous thromboembolism in patients with cancer.The coagulation system in endocrine disorders: a narrative review.Venous thrombosis at unusual sites and the role of thrombophilia.Natural history of cerebral vein thrombosis.JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review.Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.Seasonal variability of venous thromboembolism.Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment.Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention.Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy.Cerebral vein thrombosis.
P50
Q22250929-D6DC850E-C89E-4EA9-9661-B69AA862E8D8Q24240300-1BC01A9A-6B87-483E-9D85-0398D547E870Q24806932-744B6786-7D10-47C4-A4C1-33969F3E8442Q26827491-E332DB54-CD9B-45B3-A39C-6E8BD8AE6382Q26849407-2E69D097-4868-47B8-839C-DA33734F45FFQ28306773-510C31F6-B157-46A2-84C7-BBDFB2C54F31Q30784880-8E39372C-C97F-4271-BEEF-64BB9BC64FFEQ30979197-05831278-A780-4C29-A728-FF15EE95ED3CQ31158721-91E147BF-2490-4DA6-B494-E9EC20400F63Q33327083-7154FAE0-F54E-4C43-8624-0A7EE103F897Q33391910-7F949D6D-48C9-44B9-A0D4-420C959BDEE5Q33412386-B41988BC-2C80-4B92-B1CA-10A781F9505CQ33543678-ACADF1EA-2D4E-4352-8DAC-2FEC78227309Q33679476-6435E346-08B1-4B08-854D-2E0FC971434FQ33997674-529F6100-BB30-4F86-A74F-07C3588F9A37Q34019404-7A3029A9-1CEF-4257-99B3-8E24D846AD7CQ34110925-E08DB9EE-8A94-4B25-81E4-482C2BEE272AQ34161318-53DADA5C-99BA-4CDB-B4AC-A511440F868BQ34252907-F5BE8582-0101-49DE-933A-5D8A74048921Q34276812-FDA2E98D-1187-4A21-AC25-F81357CB3BFAQ34315063-F35F3CA3-4D8A-4C7E-8206-02513FAF5874Q35067214-19A5F789-6878-4253-8537-2283F2D1DBA5Q35252622-ACD2735D-C430-4CCC-B795-A5CD42D16F4EQ36286443-14CDABFF-64F1-472E-B98A-0203CF9A8254Q36556443-776A7FE8-0FFE-4E44-BA43-4A37EFCCFF9EQ36589312-74D3653F-1BC4-4876-B59E-CFE3F7FE105BQ36616091-0E2590F6-3569-4072-BE86-22E49A631DC4Q36685951-00D58F89-97BB-47D6-BC40-8B0F3D25F209Q36705104-40891758-8105-4B99-A1B3-5708FBA8CA0DQ36893601-B1B7C051-95D0-4AC8-99E9-82D5AF02DAECQ36928090-82C3189A-59EA-4155-900C-DB591D54D96AQ36973202-D087EC58-8824-4951-81A5-18FE9C6CB02DQ37410760-107573C7-9CB7-4D3B-853C-C0F5F9331BE1Q37465868-67A2A26B-6AE6-4E9A-8156-EDEF2E9F0C4DQ37510966-2DD53631-E8EB-4621-AE05-0C40DE592634Q37526185-3DD05F3B-B8D2-4DE5-BDD7-D0CAC5C54470Q37554147-A8230454-7A22-4557-8375-93E55364C045Q37554153-910F381B-7F74-4D82-B4DC-354CCBE3CDC9Q37589732-3CDE7495-00F8-4B3B-88D4-32C7451D81FFQ37641833-AE94D115-2060-4C80-A0D8-BD9A21DF920A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Walter Ageno
@ast
Walter Ageno
@en
Walter Ageno
@es
Walter Ageno
@nl
type
label
Walter Ageno
@ast
Walter Ageno
@en
Walter Ageno
@es
Walter Ageno
@nl
prefLabel
Walter Ageno
@ast
Walter Ageno
@en
Walter Ageno
@es
Walter Ageno
@nl
P106
P1153
7003949287
P21
P31
P496
0000-0002-1922-8879